Seer to Report Second Quarter 2026 Financial Results on August 11, 2026
Seer (Nasdaq: SEER) announced it will report its second quarter 2026 financial results on Tuesday, August 11, 2026.
Rhea-AI Summary
Seer (Nasdaq: SEER) announced it will report its second quarter 2026 financial results on Tuesday, August 11, 2026. Company management will host a webcasted conference call starting at 1:30 p.m. Pacific / 4:30 p.m. Eastern, with live audio and replay available on Seer’s investor website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – SEER
In the Aug 4 session, SEER declined 1.34%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Reporting period
- Q2 2026
- Financial results announcement
- Results date
- August 11, 2026
- Scheduled financial results release
- Webcast time
- 1:30 p.m. Pacific Time
- Conference call start time
- Webcast time
- 4:30 p.m. Eastern Time
- Conference call start time
Previous Earnings date Reports
-
Prior earnings-date announcement preceded a 3.72% 24-hour price reaction.
-
Prior earnings-date announcement preceded a 2.29% 24-hour price reaction.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
proteomic technical
AI-generated analysis. How Rhea-AI works. Not financial advice.
REDWOOD CITY, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the second quarter 2026 on Tuesday, August 11, 2026. Company management will be webcasting a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
Live audio of the webcast will be available on the Investor section of Seer’s website at investor.seer.bio. An archived replay will be available on the company’s website following the event.
About Seer
Seer, Inc. (Nasdaq: SEER) sets the standard in deep, unbiased proteomics, delivering insights with scale, speed, precision, and reproducibility previously unattainable by other proteomic methods. Seer's Proteograph Product Suite integrates proprietary engineered nanoparticles, automation instrumentation, optimized consumables, and advanced analytical software. Seer's products are for research use only and are not intended for diagnostic procedures. For more information, visit www.seer.bio.
Media Contact:
Patrick Schmidt
pr@seer.bio
Investor Contact:
Marissa Bych
investor@seer.bio
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.